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Figure 1. The configuration of the developed QA systems in 
this study. 
 
Results: In the mechanical isocenter offset check, the mean 
error is about 0.09 mm for gantry rotation, the maximum 
error is about 0.28 mm was measured. And the mean error is 
about 0.11 mm for collimator rotation, the maximum error is 
about 0.31 mm was measured. In the couch movement check, 
the mean error in the X-direction is about 0.17 mm, the 
mean error in the Y-direction is about 0.19 mm, and the 
mean error in the Z-direction is about 0.24 mm. 
 
Conclusion: In this study, we developed the QA system to 
improve the inefficient of the mechanical QA using 
conventional methods. At present, our QA system may 
measure the mechanical isocenter offset check and the couch 
movement check. The accuracy of measurement result is 
sufficient to measure the tolerances recommended in the 
guidelines. 
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Purpose or Objective: Purpose/Objective: To describe the 
extent of IROC Houston’s, formerly the Radiological Physics 
Center, QA activities and audit results for radiotherapy 
institutions outside of North America (NA). 
 
Material and Methods: Material/Method: The IROC Houston’s 
QA program components were designed to audit the radiation 
dose calculation chain from the NIST traceable reference 
beam calibration, to inclusion of dosimetry parameters used 
to calculate tumor doses, to the delivery of the radiation 
dose. The QA program provided to international institutions 
includes: 1) remote TLD/OSLD audit of machine output, 2) 
credentialing for advanced technologies, and 3) review of 
patient treatment records. IROC Houston uses the same 
standards and acceptance criteria for all of its audits 
whether for North American or international sites. 
 
Results: Results: IROC Houston’s QA program has reached out 
to radiotherapy sites in 43 different countries since 2013 
through their participation in clinical trials. In the past two 
years, 2,778 international megavoltage beam outputs were 
audited with OSLD/TLD. While the average IROC/Inst ratio is 
near unity for all sites monitored, there are international 
regions whose results are significantly different from the NA 
region as seen in Table 1. In the past 2 years, 477 and 87 
IMRT H&N phantoms were irradiated at NA and international 
sites, respectively. Regardless of the OSLD beam audit 
results, the overall pass rate (87 percent) for all international 
sites (no region separation) is equal to the NA sites. Of the 
182 international patient charts reviewed, 10.7 percent of 
the dose calculation points did not meet our acceptance 
criterion as compared to 13.6 percent for NA sites. The lower 
pass rate for NA sites results from a much larger 
brachytherapy component which has been shown to be more 
error prone. 
 
 
 
Conclusion: Conclusion: The IROC Houston QA Center has 
expanded its QA services worldwide and continues a long 
history of improving radiotherapy dose delivery in many 
countries. 
 
EP-1917  
Measurements of reactive oxygen species production 
induced by gold nanoparticles in radiotherapy 
P. Cerello1, L. Bocchini
1Istituto Nazionale di Fisica Nucleare INFN, Sezione di Torino, 
Torino, Italy 
1, A. Gobbato1, A. Attili1, C. Cutaia2, 
V. Ferrero3, C. Pontremoli4, L. Radici2, M. Stasi2, S. Visentin4 
2A.O. Ordine Mauriziano, Medical Physics, Torino, Italy 
3University of Torino, Department of Physics, Torino, Italy 
4University of Torino, Department of Molecular 
Biotechnology and Health Sciences, Torino, Italy 
 
Purpose or Objective: Metallic nanoparticles have shown 
radiosensitizing properties in cancer radiotherapy, with both 
conventional and hadron beams. In particular, Gold Nano 
Particles (GNPs) are emerging as promising enhancers for 
radiotherapy. However, the exact mechanisms behind the 
extra damage are yet unknown, although Reactive Oxygen 
Species (ROS) production, known to be crucial in 
radiotherapy, is a strong candidate. A direct measurements 
of ROS production was performed in typical radiotherapy 
treatment conditions. 
 
Material and Methods: A protocol for measuring the OH* 
radical production in Phosphate-buffered saline (PBS) 
solution, based on the fluorimetric properties of oxygen-
quenched Terephthalic acid, was designed and validated. 
Correction factors associated to GNP-induced adsorption, 
absorption and diffusion at the fluorimetric excitation and 
emission wavelengths were carefully evaluated. ROS 
production induced by 6 and 15 MV photon beams was then 
measured in standard PBS solution, as well as in the presence 
of GNPs of 5 nm and 20 nm diameters, at 5 μmol and 10 μmol 
concentrations. 
 
Results: A relevant ROS extra production was observed for 5 
nm diameter GNPs, up to about 40% at 10 μmol and 20% at 5 
μmol as a function of the delivered dose. Measurements with 
20 nm diameter GNPs are consistent with a ROS production 
increase of the order of 10%, albeit with a large experimental 
error. The ROS enhancement is consistent with the 
hypothesis of a linear dependence on the GNP surface to 
volume ratio, within the experimental errors. 
 
Conclusion: Further measurements with 10 nm and 2 nm 
GNPs are planned, in order to verify the linear dependence 
on the inverse GNP radius with higher precision over a wider 
size range. 
 
 
 
 
